Gene · 94241
Papers1,722
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,722
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Using Surface Immunogenic Protein as a Carrier Protein to Elicit Protective Antibody to Multiple Serotypes for Candidate Group B Streptococcal Glycan Conjugate Vaccines. | Vaccines (Basel) | 2024 | 38932301 | PubTator, text mining | PubMed |
| Repurposing metformin as adjuvant therapy in patients with ulcerative colitis treated with mesalamine: A randomized controlled double-blinded study. | Int Immunopharmacol | 2024 | 38917525 | PubTator, text mining | PubMed |
| LNA-i-miR-221 activity in colorectal cancer: A reverse translational investigation. | Mol Ther Nucleic Acids | 2024 | 38868363 | PubTator, text mining | PubMed |
| Advancing electrochemical nitrogen reduction: Efficacy of two-dimensional SiP layered structures with single-atom transition metal catalysts. | J Colloid Interface Sci | 2024 | 38685165 | PubTator, text mining | PubMed |
| Mir-155-5p targets TP53INP1 to promote proliferative phenotype in hypersensitivity pneumonitis lung fibroblasts. | Noncoding RNA Res | 2024 | 38586316 | PubTator, text mining | PubMed |
| A self-amplifying loop of TP53INP1 and P53 drives oxidative stress-induced apoptosis of bone marrow mesenchymal stem cells. | Apoptosis | 2024 | 38491252 | PubTator, text mining | PubMed |
| Oncopig bladder cancer cells recapitulate human bladder cancer treatment responses in vitro. | Front Oncol | 2024 | 38469237 | PubTator, text mining | PubMed |
| STK3 kinase activation inhibits tumor proliferation through FOXO1-TP53INP1/P21 pathway in esophageal squamous cell carcinoma. | Cell Oncol (Dordr) | 2024 | 38436783 | PubTator, text mining | PubMed |
| Identification of a Novel Gene Expression Signature Associated with Amino Acid Metabolism (AAM) in Ankylosing Spondylitis (AS). | Int J Gen Med | 2024 | 38405617 | PubTator, text mining | PubMed |
| Exploring miR-155-5p and miR-1246 as Diagnostic and Prognostic Markers in Oral Squamous cell carcinoma. | Mol Biol Rep | 2024 | 38400867 | PubTator, text mining | PubMed |
| Wide-angle non-uniform optical phased array using compact and efficient antenna design. | Sci Rep | 2024 | 38360898 | PubTator, text mining | PubMed |
| A first-principles study of 2D single-layer SiP as anode materials for lithium-ion batteries and sodium-ion batteries. | Phys Chem Chem Phys | 2024 | 38345652 | PubTator, text mining | PubMed |
| The chromatin-associated lncREST ensures effective replication stress response by promoting the assembly of fork signaling factors. | Nat Commun | 2024 | 38302450 | PubTator, text mining | PubMed |
| Exosomal microRNAs in regulation of tumor cells resistance to apoptosis. | Biochem Biophys Rep | 2024 | 38298209 | PubTator, text mining | PubMed |
| Circular RNA-mediated miRNA sponge & RNA binding protein in biological modulation of breast cancer. | Noncoding RNA Res | 2024 | 38282696 | PubTator, text mining | PubMed |
| Insights into How Plant-Derived Extracts and Compounds Can Help in the Prevention and Treatment of Keloid Disease: Established and Emerging Therapeutic Targets. | Int J Mol Sci | 2024 | 38279232 | PubTator, text mining | PubMed |
| An approach for an enhanced anticancer activity of ferulic acid-loaded polymeric micelles via MicroRNA-221 mediated activation of TP53INP1 in caco-2 cell line. | Sci Rep | 2024 | 38267567 | PubTator, text mining | PubMed |
| Differential Gene Expression in Human Fibroblasts Simultaneously Exposed to Ionizing Radiation and Simulated Microgravity. | Biomolecules | 2024 | 38254688 | PubTator, text mining | PubMed |
| Epitranscriptomics m6A analyses reveal distinct m6A marks under tumor necrosis factor α (TNF-α)-induced apoptotic conditions in HeLa cells. | J Cell Physiol | 2024 | 38179601 | PubTator, text mining | PubMed |
| Cellular zinc metabolism and zinc signaling: from biological functions to diseases and therapeutic targets. | Signal Transduct Target Ther | 2024 | 38169461 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/94241/papers?page=4